Lee, S.; Yang, S.; Shim, W.-S.; Song, E.; Han, S.; Park, S.-S.; Choi, S.; Joo, S.H.; Park, S.J.; Shin, B.;
et al. Development and Validation of an Improved HPLC-MS/MS Method for Quantifying Total and Unbound Lenalidomide in Human Plasma. Pharmaceutics 2024, 16, 1340.
https://doi.org/10.3390/pharmaceutics16101340
AMA Style
Lee S, Yang S, Shim W-S, Song E, Han S, Park S-S, Choi S, Joo SH, Park SJ, Shin B,
et al. Development and Validation of an Improved HPLC-MS/MS Method for Quantifying Total and Unbound Lenalidomide in Human Plasma. Pharmaceutics. 2024; 16(10):1340.
https://doi.org/10.3390/pharmaceutics16101340
Chicago/Turabian Style
Lee, Suhyun, Seungwon Yang, Wang-Seob Shim, Eunseo Song, Seunghoon Han, Sung-Soo Park, Suein Choi, Sung Hwan Joo, Seok Jun Park, Beomjin Shin,
and et al. 2024. "Development and Validation of an Improved HPLC-MS/MS Method for Quantifying Total and Unbound Lenalidomide in Human Plasma" Pharmaceutics 16, no. 10: 1340.
https://doi.org/10.3390/pharmaceutics16101340
APA Style
Lee, S., Yang, S., Shim, W.-S., Song, E., Han, S., Park, S.-S., Choi, S., Joo, S. H., Park, S. J., Shin, B., Kim, D., Kim, H., Jung, Y., Lee, K.-T., & Chung, E. K.
(2024). Development and Validation of an Improved HPLC-MS/MS Method for Quantifying Total and Unbound Lenalidomide in Human Plasma. Pharmaceutics, 16(10), 1340.
https://doi.org/10.3390/pharmaceutics16101340
